SHARE-BASED PAYMENT - Summary of Restricted shares granted to employees and directors (Details) - Restricted Shares - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Number of options | |||
| Outstanding, Beginning balance | 38,644,400 | 40,318,000 | |
| Granted | 38,644,400 | 87,737,000 | |
| Exercised | (38,644,400) | (40,318,000) | (47,419,000) |
| Outstanding, Ending balance | 38,644,400 | 40,318,000 | |
| Weighted average grant date fair value per share | |||
| Outstanding, Beginning balance | $ 0.03 | $ 0.03 | |
| Granted | 0.03 | $ 0.02 | |
| Exercised | $ 0.03 | 0.03 | 0.02 |
| Outstanding, Ending balance | $ 0.03 | $ 0.03 | |
| Aggregated intrinsic value | |||
| Outstanding, Beginning Balance | $ 974 | $ 2,032 | |
| Granted | 1,070 | $ 1,955 | |
| Exercised | $ 1,070 | 1,201 | 754 |
| Outstanding, Ending Balance | $ 974 | $ 2,032 | |
| X | ||||||||||
- Definition Intrinsic value of exercised award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of granted award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that exercised during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were exercised or put into effect as a result of the occurrence of a terminating event. No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|